Artificial Intelligence and Machine Learning

Example outputs with biopsy-verified GG2 or higher PCa

Cambridge University spin-out Lucida Medical secures substantial funding to develop AI for cancer screening

Cambridge, UK – 19 March 2021. Cambridge start-up Lucida Medical has raised significant seed capital from a group of investors led by XTX Ventures and Prostate Cancer Research. The multi-million-pound investment is a major advance towards Lucida Medical’s goal to disrupt the cancer diagnostic pathway with technology that finds cancer more accurately by analysing MRI, […]

Cambridge University spin-out Lucida Medical secures substantial funding to develop AI for cancer screening Read More »

Medical device software and AI – key new guidance

We now have a new key document providing guidance on the EU Medical Devices Regulation (MDR), which comes into full force in 2020. While it’s a highly technical document, developers and researchers targeting medical device software and AI algorithms with medical purposes need to understand its contents. The Medical Devices Regulation (EU Regulation 2017/745) is

Medical device software and AI – key new guidance Read More »

Artificial intelligence AI overview

What is AI?

… or what’s intelligent about machine learning? Artificial intelligence (AI) is already having a significant impact, and has tremendous potential to make our lives better still. Yet it is a broad term and is often misunderstood as science fiction rather than software – which is why practitioners often prefer to use the term Machine Learning

What is AI? Read More »

Winners of CWDS2018 - Conigital, Tethir and Granta Innovation

Winners of CWDS2018

We’re delighted to announce that Granta Innovation was selected as one of three winners of CW (Cambridge Wireless) Discovering Startups, an annual competition to find the most promising early stage companies in the Cambridge tech ecosystem. 12 companies pitched to a distinguished panel of judges including technology experts, entrepreneurs, angel and venture capital investors. Dr

Winners of CWDS2018 Read More »